一种基于对应的网络方法,用于对特定患者的时空数据进行分组分析
Penny R Atkins1,2, Alan Morris1, Shireen Y Elhabian1,3
1Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, UT, USA.
Annals of biomedical engineering
|June 25, 2023
概括
一种新的基于通信的网络分析方法改善了对患者特定空间和时间数据的统计分析. 与传统方法相比,这种方法通过识别更广泛,更连接的显著区域来增强临床解释.
科学领域:
- 生物医学工程 生物医学工程
- 医学图像分析 医学图像分析
- 统计分析 统计分析
背景情况:
- 分析患者特定的时空数据具有挑战性,通常需要复杂的表面登记或有限的总结统计数据.
- 现有的方法在复杂的生物数据的统计分析中难以保持主体和空间特异性.
研究的目的:
- 引入和评估一种新的基于通信的网络分析 (CBNA) 方法,用于对特定患者的时空数据进行统计分析.
- 使用关节相关的生物力学数据集,将CBNA的性能与传统的统计参数映射 (SPM) 进行比较.
主要方法:
- 开发了一种基于粒子的形状建模方法,以建立全人口的对应性.
- 应用CBNA和传统SPM来分析皮质骨厚度,软骨接触应力和关节数据集中的动态关节空间.
- 使用这两种方法评估了基于团体和活动的差异.
主要成果:
- 与SPM不同,CBNA对信函密度表现出不敏感,SPM显示密度增加的显著区域减少.
- 在所有三个评估的部数据集中,CBNA确定了更广泛,更相互连接的重要区域.
- CBNA保留了主题和空间特异性,在识别群体和活动差异方面表现优于SPM.
结论:
- 基于对应的网络分析为分析复杂的特定患者的时空数据提供了强大的替代方案.
- 通过揭示显著差异而不会牺牲特异性,CBNA方法提高了统计能力和临床解释性.
- 这种方法有可能改善临床环境中的诊断准确性和治疗规划.
相关概念视频
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
99
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
99
01:12Analysis of Population Pharmacokinetic Data
301
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
301
01:20Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
01:11Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K